EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Exploring the Application Potential of α-Synuclein Molecular Probes in Early Diagnosis of Parkinson’s Disease: Focus on Imaging Methods

Qiyuan Sun iD, Mingmin Wu, Runxia Xie, Lingfeng Lai iD, Qiujie Chen, Jitian Guan iD

ACS Chemical Neuroscience · 2025

DOI: 10.1021/acschemneuro.5c00008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Qiyuan Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, Longgang District Central Hospital of Shenzhen, Shenzhen 518116, China. Hauptthemen laut MEDLINE: Parkinson Disease, alpha-Synuclein, Molecular Probes, Neuroimaging. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangdong Science and Technology Department, Basic and Applied Basic Research Foundation of Guangdong Province, Shenzhen Longgang District Science and Technology Innovation Special Fund Medical and Health Technology Plan Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review aims to explore the potential application of α-synuclein (α-syn) molecular probes in the early diagnosis of Parkinson's disease (PD), particularly through systematic evaluation using medical imaging methods. In recent years, The abnormal aggregation of α-syn within the central nervous system is now recognized as a central driver of PD pathophysiology, solidifying its role as a critical diagnostic and prognostic biomarker. Early diagnosis of PD is critical for enabling precision therapeutic interventions and mitigating neurodegenerative progression, thereby enhancing long-term functional outcomes and the quality of life. However, challenges remain in clinical practice, particularly concerning the late timing of diagnosis and the lack of specific biomarkers. By analyzing the existing literature, we will assess the effectiveness of different imaging techniques combined with α-syn probes and discuss their advantages and limitations in clinical applications. These imaging methods can provide visualization of early pathological changes, helping to improve the recognition rate of PD. Finally, we emphasize the importance of future research to explore new molecular probes and imaging technologies that can improve early diagnosis rates and treatment outcomes for PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson Diseasealpha-SynucleinMolecular ProbesNeuroimagingHumansEarly DiagnosisAnimalsBiomarkers

Stichwörter der Autor:innen

Parkinson’s diseasebiomarkermedical imagingmolecular probesα-synuclein

Substanzen

alpha-SynucleinMolecular ProbesBiomarkers

Autor:innen und Institutionen

  • Department of Medical Imaging, Longgang District Central Hospital of Shenzhen, Shenzhen 518116, China.
  • Department of Radiology, Second Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong 515041, China.

ORCID-Profile: Qiyuan Sun, Lingfeng Lai, Jitian Guan

Förderung

  • Guangdong Science and Technology Department
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Shenzhen Longgang District Science and Technology Innovation Special Fund Medical and Health Technology Plan Project

Zitieren

APA

Sun, Q., Wu, M., Xie, R., Lai, L., Chen, Q., & Guan, J. (2025). Exploring the Application Potential of α-Synuclein Molecular Probes in Early Diagnosis of Parkinson’s Disease: Focus on Imaging Methods. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00008

Vancouver

Sun Q, Wu M, Xie R, Lai L, Chen Q, Guan J. Exploring the Application Potential of α-Synuclein Molecular Probes in Early Diagnosis of Parkinson’s Disease: Focus on Imaging Methods. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00008

BibTeX
@article{Sun2025,
  author = {Sun, Qiyuan and Wu, Mingmin and Xie, Runxia and Lai, Lingfeng and Chen, Qiujie and Guan, Jitian},
  title = {Exploring the Application Potential of α-Synuclein Molecular Probes in Early Diagnosis of Parkinson’s Disease: Focus on Imaging Methods},
  journal = {ACS Chemical Neuroscience},
  year = {2025},
  doi = {10.1021/acschemneuro.5c00008}
}
Kostenlos starten →